Axis for change Manifesto
Commercial Strategy Optimization
Oncology & Hematology
Pre-launch
Precision Medicine Readiness Report 2/3
Abstract
In this Axis for Change manifesto, we wish to enable collaboration around a new systems level approach aiming to reduce time to optimized testing from years (current average is 4.5 years) to months.
The second report in the series uses NSCLC as a disease-level sandbox to illustrative the flaws in the current diagnostic ecosystem.
Discover the final report in our Axis for Change Manifesto.
Download Report
You might also be interested in?
Rethinking Drug Commercialization: Navigating a Shifting Biotech Investment Landscape
Explore strategies for biotech commercialization amid evolving investment landscapes, focusing on precision and rare disease therapies. Join industry experts in navigating funding challenges and enhancing patient outcomes.
Commercial Strategy Optimization